Blog
Latest articles, insights, and updates from the blog.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
Telehealth Ketamine Marketing Compliance: Regulatory and Ethical Guidelines
What rules govern telehealth ketamine advertising? Review of FDA, FTC, and state guidance on marketing low-dose ketamine therapy through virtual platforms.
Ketamine Side Effects: A Complete Clinical Guide
Comprehensive evidence-based review of ketamine side effects including dissociation, nausea, cardiovascular changes, and cognitive effects for clinicians.
Sub-Anesthetic Ketamine for Fibromyalgia: Analgesic Mechanisms and Outcomes
Evidence review of sub-anesthetic ketamine for fibromyalgia pain, examining central sensitization reversal, NMDA receptor mechanisms, and clinical outcomes from infusion studies.
Ketamine Tolerance and Long-Term Use: What Clinicians Need to Know
Clinical review of tolerance development during long-term ketamine therapy, including mechanisms, detection strategies, and evidence-based management approaches.
Managing Nausea and Vomiting During Ketamine Therapy
Clinical guide to preventing and treating ketamine-induced nausea and vomiting, covering antiemetic protocols, risk factors, and non-pharmacological strategies.
Cognitive Effects of Repeated Low-Dose Ketamine: Neuropsychological Assessment
Does repeated low-dose ketamine affect cognition? Review of memory, attention, and executive function testing across short- and longer-term treatment courses.
Does Ketamine Affect Sleep? Low-Dose Ketamine and Sleep Architecture
Does ketamine affect sleep? Review of how low-dose ketamine influences sleep quality, insomnia, and sleep architecture in depression and chronic pain patients.
Measuring Ketamine Treatment Outcomes: Validated Assessment Tools
How is ketamine response actually measured? A review of validated depression scales, suicidality tools, functional assessments, and biomarkers used in trials.
Esketamine vs Racemic Ketamine Dosing: Comparative Pharmacology
How do esketamine and racemic ketamine doses compare? Review of enantiomer pharmacology, potency differences, route-specific dosing, and clinical equivalencies.
Anti-Inflammatory Properties of Low-Dose Ketamine: Cytokine Modulation
Review of the anti-inflammatory properties of low-dose ketamine, examining cytokine modulation, NF-kappaB signaling, microglial inhibition, and implications for depression and pain.
BDNF Signaling and Ketamine's Antidepressant Action
A detailed examination of how ketamine activates brain-derived neurotrophic factor signaling, TrkB receptor pathways, and the mTOR cascade to produce rapid antidepressant effects. Covers molecular mechanisms, clinical evidence, and implications for personalized treatment.
Ketamine-Assisted Therapy for Substance Use Disorders: Clinical Trials Review
Review of ketamine-assisted therapy for substance use disorders including alcohol, cocaine, and opioid dependence — examining clinical trials, neuroplasticity mechanisms, and outcomes.